Injective (INJ) is currently priced at $3.25, reflecting an 8.74% increase over the past 24 hours. The asset has experienced a daily trading range between $2.98 and $3.41, indicating strong volatility and market interest.

The trading volume stands at approximately $87.33 million, representing 26.90% of its market capitalization, suggesting healthy liquidity. The hourly moving averages show a mixed sentiment; the 8 SMA is flat at $3.25, while longer-term SMAs indicate bullish momentum, particularly the 55 SMA at $3.05, which is up 6.68%.

In terms of momentum indicators, the 1-hour RSI is at 68, nearing overbought territory, while the 7-day RSI is at a more moderate 56. The 7-day price change is positive at 11.14%, indicating a strong short-term bullish trend, while the 14-day price change also supports this with a 13.01% gain.

However, the 30-day price change is negative at -2.35%, suggesting potential resistance at higher price levels. This divergence in short-term gains versus longer-term performance may indicate a consolidation phase or a pullback in the near future.

Given the recent upward movement and the current technical indicators, the short-term outlook for INJ is positive, but caution is warranted due to the high RSI and previous price performance.

Overall, the market sentiment is leaning towards bullish, but the potential for a correction exists. Therefore, the recommendation for Injective (INJ) is a Hold, as traders should monitor for signs of strength or weakness before making any aggressive moves.